Targeting prognostic proinflammatory biomarkers to improve outcome on IO drugs.
John Haanen
More about this publication
ESMO open
Volume
4
Issue nr.
4
Pages
e000557
Publication date
20-08-2019
Full text links
Publisher website (DOI)
10.1136/esmoopen-2019-000557
Europe PubMed Central
31423339
Pubmed
31423339